These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 22832988)

  • 1. Characterization of five novel endolysins from Gram-negative infecting bacteriophages.
    Walmagh M; Boczkowska B; Grymonprez B; Briers Y; Drulis-Kawa Z; Lavigne R
    Appl Microbiol Biotechnol; 2013 May; 97(10):4369-75. PubMed ID: 22832988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muralytic activity and modular structure of the endolysins of Pseudomonas aeruginosa bacteriophages phiKZ and EL.
    Briers Y; Volckaert G; Cornelissen A; Lagaert S; Michiels CW; Hertveldt K; Lavigne R
    Mol Microbiol; 2007 Sep; 65(5):1334-44. PubMed ID: 17697255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effect of SAR-endolysin LysKpV475 with polymyxin B and
    Gontijo M; Pereira Teles M; Martins Correia H; Pérez Jorge G; Rodrigues Santos Goes IC; Fasabi Flores AJ; Braz M; de Moraes Ceseti L; Zonzini Ramos P; Rosa E Silva I; Pereira Vidigal PM; Kobarg J; Miguez Couñago R; Alvarez-Martinez CE; Pereira C; Freire CSR; Almeida A; Brocchi M
    Microbiology (Reading); 2024 May; 170(5):. PubMed ID: 38739436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Screening, and Characterization of Engineered Phage Endolysins with Extracellular Antibacterial Activity against Gram-Negative Bacteria.
    Sui B; Wang X; Zhao T; Zhen J; Ren H; Liu W; Zhang X; Zhang C
    Appl Environ Microbiol; 2023 Jul; 89(7):e0058123. PubMed ID: 37338346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of modular bacteriophage endolysins from Myoviridae phages OBP, 201φ2-1 and PVP-SE1.
    Walmagh M; Briers Y; dos Santos SB; Azeredo J; Lavigne R
    PLoS One; 2012; 7(5):e36991. PubMed ID: 22615864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting phage receptor binding proteins to enable endolysins to kill Gram-negative bacteria.
    Zampara A; Sørensen MCH; Grimon D; Antenucci F; Vitt AR; Bortolaia V; Briers Y; Brøndsted L
    Sci Rep; 2020 Jul; 10(1):12087. PubMed ID: 32694655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous lytic activity of SPN9CC endolysin against gram-negative bacteria.
    Lim JA; Shin H; Heu S; Ryu S
    J Microbiol Biotechnol; 2014 Jun; 24(6):803-11. PubMed ID: 24690638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriophage endolysins--current state of research and applications.
    Loessner MJ
    Curr Opin Microbiol; 2005 Aug; 8(4):480-7. PubMed ID: 15979390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Three Different Endolysins Effective against Gram-Negative Bacteria.
    Jeong TH; Hong HW; Kim MS; Song M; Myung H
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DUF3380 Domain from a Salmonella Phage Endolysin Shows Potent N-Acetylmuramidase Activity.
    Rodríguez-Rubio L; Gerstmans H; Thorpe S; Mesnage S; Lavigne R; Briers Y
    Appl Environ Microbiol; 2016 Aug; 82(16):4975-81. PubMed ID: 27287318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidoglycan degrading activity of the broad-range Salmonella bacteriophage S-394 recombinant endolysin.
    Legotsky SA; Vlasova KY; Priyma AD; Shneider MM; Pugachev VG; Totmenina OD; Kabanov AV; Miroshnikov KA; Klyachko NL
    Biochimie; 2014 Dec; 107 Pt B():293-9. PubMed ID: 25241254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Salmonella endolysin XFII produced by recombinant Escherichia coli and its application combined with chitosan in lysing Gram-negative bacteria.
    Zhang S; Chang Y; Zhang Q; Yuan Y; Qi Q; Lu X
    Microb Cell Fact; 2022 Aug; 21(1):171. PubMed ID: 35999567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activity of prophage endolysins against critical Enterobacteriaceae antibiotic-resistant bacteria.
    Gonçalves T; Marques AT; Manageiro V; Tanoeiro L; Vital JS; Duarte A; Vítor JMB; Caniça M; Gaspar MM; Vale FF
    Int J Pharm; 2024 Feb; 651():123758. PubMed ID: 38160991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From endolysins to Artilysin®s: novel enzyme-based approaches to kill drug-resistant bacteria.
    Gerstmans H; Rodríguez-Rubio L; Lavigne R; Briers Y
    Biochem Soc Trans; 2016 Feb; 44(1):123-8. PubMed ID: 26862197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Artilysation' of endolysin λSa2lys strongly improves its enzymatic and antibacterial activity against streptococci.
    Rodríguez-Rubio L; Chang WL; Gutiérrez D; Lavigne R; Martínez B; Rodríguez A; Govers SK; Aertsen A; Hirl C; Biebl M; Briers Y; García P
    Sci Rep; 2016 Oct; 6():35382. PubMed ID: 27775093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure and function of modular Escherichia coli O157:H7 bacteriophage FTBEc1 endolysin, LysT84: defining a new endolysin catalytic subfamily.
    Love MJ; Coombes D; Ismail S; Billington C; Dobson RCJ
    Biochem J; 2022 Jan; 479(2):207-223. PubMed ID: 34935873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the efficacy of endolysins and membrane permeabilizers against Vibrio parahaemolyticus in marine conditions.
    Zermeño-Cervantes LA; Martínez-Díaz SF; Venancio-Landeros AA; Cardona-Félix CS
    Res Microbiol; 2023; 174(7):104104. PubMed ID: 37422006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phage endolysins with broad antimicrobial activity against Enterococcus faecalis clinical strains.
    Proença D; Fernandes S; Leandro C; Silva FA; Santos S; Lopes F; Mato R; Cavaco-Silva P; Pimentel M; São-José C
    Microb Drug Resist; 2012 Jun; 18(3):322-32. PubMed ID: 22480295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of the engineered endolysin mtEC340M.
    Wang JM; Seok SH; Yoon WS; Kim JH; Seo MD
    Acta Crystallogr F Struct Biol Commun; 2023 May; 79(Pt 5):105-110. PubMed ID: 37132476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriophages, phage endolysins and antimicrobial peptides - the possibilities for their common use to combat infections and in the design of new drugs.
    Mirski T; Lidia M; Nakonieczna A; Gryko R
    Ann Agric Environ Med; 2019 Jun; 26(2):203-209. PubMed ID: 31232046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.